Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,795 public trials 654 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity trial results

Completed

Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)

NCT06353087

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +10 more
Locations
  • Kaohsiung Medical University Hospital Kaohsiung City, Taiwan
  • Chang Gung Memorial Hospital at Kaohsiung Kaohsiung City, Taiwan
  • Taipei Medical University - Shuang Ho Hospital New Taipei City, Taiwan
  • NTUH Taipei, Taiwan
View Trial Details
Completed

An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in China

NCT06421740

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Beijing Anzhen Hospital /ID# 273443 Beijing, Beijing Municipality, China
  • China-Japan Friendship Hospital /ID# 274778 Beijing, Beijing Municipality, China
  • Peking University First Hospital /ID# 274865 Beijing, Beijing Municipality, China
  • Peking Unversity Third hospital /ID# 274864 Beijing, Beijing Municipality, China
View all 38 locations
View Trial Details
Completed

Severe Asthma Research Program

NCT01606826

Conditions
Asthma, Bronchial Diseases, Hemic and Lymphatic Diseases, +15 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Brigham & Women's Hospital Boston, Massachusetts, United States
  • Children's Hospital, Boston Boston, Massachusetts, United States
  • Washington University St Louis, Missouri, United States
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)

NCT06181435

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations
  • Center for Dermatology and Plastic Surgery- Site Number : 8401119 Scottsdale, Arizona, United States
  • Eclipse Clinical Research- Site Number : 8401158 Tucson, Arizona, United States
  • Torrance Clinical Research- Site Number : 8401027 Lomita, California, United States
  • Dermatology Research Associates - Los Angeles- Site Number : 8401092 Los Angeles, California, United States
View all 142 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids

NCT06224348

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations
  • Cahaba Dermatology & Skin Health Center- Site Number : 8401066 Birmingham, Alabama, United States
  • Johnson Dermatology- Site Number : 8401076 Fort Smith, Arkansas, United States
  • Encino Research Center- Site Number : 8401042 Encino, California, United States
  • Marvel Clinical Research- Site Number : 8401102 Huntington Beach, California, United States
View all 167 locations
View Trial Details

Related conditions